Seminars in Liver Disease

Papers
(The H4-Index of Seminars in Liver Disease is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Critical Care Management of Acute-on-Chronic Liver Failure: Certainties and Unknowns99
A Precision Medicine Guided Approach to the Utilization of Biomarkers in MASLD51
Tight Junction Proteins as Therapeutic Targets to Treat Liver Fibrosis and Hepatocellular Carcinoma36
Hepatic Extracellular Matrix and Its Role in the Regulation of Liver Phenotype34
Expert Practical Recommendations for Hepatocellular Carcinoma34
Patient-Reported Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease28
Genetic and Epigenetic Basis of Drug-Induced Liver Injury26
HBV Biomarkers and Their Role in Guiding Treatment Decisions25
Emerging Targets for the Treatment of Primary Sclerosing Cholangitis23
Tailored Model of Care for Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease23
Genetic Contributions to Biliary Atresia: A Developmental Cholangiopathy22
Growth Hormone Signaling in Liver Diseases: Therapeutic Potentials and Controversies19
Alcohol Plus Additional Risk Factors: Rodent Model of Liver Injury19
Physiomimetic In Vitro Human Models for Viral Infection in the Liver18
Mice Engrafted with Human Liver Cells18
Wilson Disease: Novel Diagnostic and Therapeutic Approaches18
Patient-Derived Models of Liver Cancer to Inform Clinical Treatment Paradigms: Recent Updates17
0.13597702980042